Brief: Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay
05/02/2025 21:22
Feb 5 (Reuters) - Myriad Genetics Inc MYGN.O :
* MYRIAD GENETICS ANNOUNCES TWO NEW PATENTS GRANTED FOR ITS
MOLECULAR RESIDUAL DISEASE (MRD) ASSAY
Source text: ID:nGNX20YtBb
Further company coverage: MYGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple